# HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

Source: https://onco.cc/trials/nct07396584/  
OnCo record `nct07396584` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of HMPL-A580 in advanced solid tumours, run by Hutchmed, now recruiting.

## Summary

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor is a phase 1/2 interventional study registered as NCT07396584 by Hutchmed, with 186 participants planned, started 2026-03-04 and due to reach its primary completion in 2028-12-31. Interventions recorded: HMPL-A580.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07396584
- Phase: 1/2
- Setting: A Phase I/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumors
- Sponsor: Hutchmed
- Enrolled: 186

## Sources

- ClinicalTrials.gov NCT07396584: https://clinicaltrials.gov/study/NCT07396584

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- companies: [Hutchmed](https://onco.cc/companies/hutchmed/)

---
JSON: https://onco.cc/api/v1/entities/nct07396584.json